Sign Up to like & get
recommendations!
1
Published in 2022 at "AAPS PharmSciTech"
DOI: 10.1208/s12249-022-02272-2
Abstract: Lovastatin (Lov) is a lipid-lowering agent, with 5% bioavailability (BA) due to extensive first pass metabolism and poor solubility. To enhance dissolution and in vivo effects, Lov solid self microemulsifying drug delivery system (SMEDDS) and…
read more here.
Keywords:
smedds liquisolid;
dissolution;
vivo effects;
solid smedds ... See more keywords